Investing
EU antitrust regulators set Oct. 19 deadline for Pfizer’s Seagen deal
© Reuters. Test tubes are seen in front of Seagen logo in this illustration taken June 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
BRUSSELS (Reuters) – Pfizer (NYSE:)’s $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday.
U.S. pharmaceutical company Pfizer announced the deal, its biggest, in March for Washington-based Seagen, a pioneer of antibody-drug conjugates, which work like “guided missiles” designed to destroy cancer while sparing healthy cells.
The European Commission can either clear the deal after a preliminary review or it can start a four-month long investigation if it has serious concerns.
Pfizer sought EU antitrust approval on Thursday.
Read the full article here
-
Investing7 days ago
Bank regulator gives BlackRock new deadline on bank stakes, Bloomberg reports By Reuters
-
Side Hustles3 days ago
Why the Best CEOs Think Like Anthropologists
-
Side Hustles6 days ago
How to Craft Marketing Campaigns That Reach Multiple Generations
-
Side Hustles6 days ago
LA Rental Prices Skyrocketing Despite Price Gouging Laws
-
Make Money4 days ago
Earn More in 2025: Top 10 High-Yield Savings Accounts Revealed
-
Side Hustles7 days ago
Former Zillow Execs Target $1.3T Market
-
Side Hustles4 days ago
What to Do If TikTok is Banned — How to Protect Your Brand
-
Passive Income4 days ago
How Pets Can Promote Better Health and Well-Being in the Workplace